Belysse Group (BELYS) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
20 Oct, 2025Executive summary
H1 2025 consolidated revenue was €134.6m, down 7% year-over-year, with Europe declining 14.7% and the US stable.
Adjusted EBITDA fell 19.6% to €17.3m, with margin dropping to 12.8% from 14.8%.
US division maintained stable revenue and improved profitability, while Europe faced volume declines and market softness, especially in residential.
Net loss for H1 2025 was €0.08m, compared to a profit of €10.5m in H1 2024.
Leadership change in the US division with a new Interim President appointed in August 2025.
Financial highlights
Q2 2025 revenue was €67.4m, down 9.5% year-over-year, with US down 4.4% and Europe down 16.3%.
US H1 2025 revenue: €75.9m (flat), Europe: €58.7m (down 14.7%).
Adjusted EBITDA: €17.3m (down from €21.5m), US: €15.6m (+8.2%), Europe: €1.7m (-76%).
Net loss: €0.08m vs. profit of €10.5m year-over-year.
Net debt at period end: €126.8m (including IFRS 16), leverage at 3.5x (up from 3.1x at end-2024).
Outlook and guidance
Management expects lingering but diminishing effects from the phase-out of low-margin European product lines in H2 2025, with no major impact anticipated for 2026.
Market softness in Europe, especially in residential, is expected to persist; US business expected to maintain stable volumes and profitability.
No specific margin or volume guidance provided, but management believes market softness is cyclical, not structural.
Q3 2025 trading update scheduled for October 2025.
Latest events from Belysse Group
- Revenue and EBITDA declined, leverage rose, but sustainability targets were exceeded.BELYS
H2 202513 Mar 2026 - Adjusted EBITDA up 75% despite 7% revenue drop; leverage and liquidity improved.BELYS
H1 202423 Jan 2026 - Adjusted EBITDA up 26% and leverage down to 3.1x despite revenue decline.BELYS
H2 202426 Dec 2025 - Q3 2025 revenue dropped 10.9% YoY to €60.6m, with lower EBITDA and ongoing market headwinds.BELYS
Q3 2025 TU20 Oct 2025 - Q1 revenue fell 8.3% YoY, but adjusted EBITDA and leverage improved significantly.BELYS
Q1 2024 TU4 Jun 2025 - Q3 2024 revenue declined 7.6% year-over-year, led by weakness in Europe.BELYS
Q3 2024 TU4 Jun 2025